doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: depo

1 - 5 of 20 <<previous | next>>

Drugs results:

Rosuvastatin pills

Rosuvastatin

Rosuvastatin is an HMG CoA reductase inhibitor which is also known as “statins” group. A class of drug that works by blocking the production of cholesterol (a type of fat) in the body. Indications: for primary hypercholesterolemia (excessive choleteste more...

Modafinil

Modafinil

Modafinil improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy and shift work sleep disorder (SWSD); adjunctive therapy for obstructive sleep apnea/hypopnea syndrome (OSAHS). more...

Medroxyprogesterone tablets

Medroxyprogesterone

Medroxyprogesterone contains Progestins or hormones. Progestins are prescribed for several reasons: to properly regulate the menstrual cycle and treat unusual stopping of the menstrual periods; to help a pregnancy occur during egg donor or infertility pr more...

Colchicine

Colchicine

Colchicine is a medication used to treat gout attacks. Colchicine is a poisonous pale yellow extract from the autumn crocus. In addition to treating gout it is used in plant breeding science. When taking colchicine it is very important to contact your more...

Diseases results:

Reduce cholesterol
Narcolepsy
Contraception
Gout
Birth control
Angina
Joint pain
Anemia

Articles results:

First DataBank Agrees To Tentative Settlement In Suit Over Prescription Drug Average Wholesale Prices
Publisher First DataBank has agreed to a tentative settlement with plaintiffs in a lawsuit that alleges the company colluded with prescription drug wholesaler McKesson to raise the average wholesale prices of prescription drugs to increase pharmacy profits and win business for McKesson, the Wall Street Journal reports.


UW-Madison Researchers Clear Way To Stronger Glass
Look at your window - not out it, but at it. Though the window glass looks clear, if you could peer inside the pane you would see a surprising molecular mess, with tiny particles jumbled together any which way.Now, researchers at the University of Wisconsin-Madison have developed a new glass-making technique that eliminates some of that mess.


Unusually Stable Glasses May Benefit Drugs, Coatings
Just spray and chill. That sums up a new approach to making remarkably stable glassy materials from organic (carbon-containing) molecules that could lead to novel coatings and to improvements in drug delivery. The processing advance is reported in this week's issue of Science* by scientists from the University of Wisconsin-Madison and the National Institute of Standards and Technology (NIST) Center for Neutron Research (NCNR).


Novel Treatment For ADHD - Shire And New River Pharmaceuticals Announce FDA Approval Of The First And Only Stimulant Prodrug VYVANSE
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). On February 20, 2007 Shire and New River announced an agreement whereby Shire will acquire New River for approximately $2.


EMEA CMPH Use Adopts 5 Positive Opinions Recommending The Granting Of A Marketing Authorisation For The Following Medicinal Products
-- Aerinaze (desloratadine 2.5 mg/pseudoephedrine sulphate 120 mg), from Schering-Plough Europe, for the symptomatic treatment of seasonal allergic rhinitis, accompanied by nasal congestion. EMEA review began on 26 July 2006 with an active review time of 196 days.




1 - 5 of 20 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.